Transfection Reagents & Equipment Market Size, Share & Trends Report

Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report By Method (Electroporation, Adenoviral Vectors), By Application (Transgenic Models), By Region, And Segment Forecasts, 2020 - 2025

  • Report ID: 978-1-68038-715-5
  • Number of Pages: 135
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2018
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the transfection reagents & equipment market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for transfection reagents & equipment market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of transfection reagents & equipment market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Transfection Reagents & Equipment Market Categorization:

The transfection reagents & equipment market was categorized into four segments, namely product (Reagents, Equipment), method (Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate, DEAE-dextran, Magnetic Beads, Activated Dendrimers, Laserfection), application (Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research, Biomedical Research), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The transfection reagents & equipment market was segmented into product, method, application, and region. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The transfection reagents & equipment market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into eight countries, namely, the U.S.; Canada; Germany; the UK; Japan; China; Brazil; South Africa.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Transfection reagents & equipment market companies & financials:

The transfection reagents & equipment market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • THERMO FISHER SCIENTIFIC INC. - Fisher Scientific and Thermo Electron collaborated to become the publicly traded biotechnology business Thermo Fisher Scientific, Inc. Thermo Fisher offers products in the fields of clinical diagnostics, industrial and applied sciences, and life sciences. With operations in more than 50 nations, the firm sells its products under the following brands: Fisher Scientific, Thermo Scientific, Invitrogen, Unity Lab Services, and Applied Biosystems. Since April 2013, the Life Technologies Corporation has become a Thermo Fisher subsidiary. In March 2016, Affymetrix, Inc. was bought.

  • PROMEGA CORPORATION - Global biotechnology firm Promega Corporation offers products and services for genetics DNA markers, protein enzymes, energy metabolism, PCR, biologics, and cell analysis. They provide almost 4,000 goods in their catalogue, along with bioinformatics and technical assistance. The firm has distribution centres in 100 countries and operates in more than 16 nations. Promega is the owner of many patents in the fields of bioluminescence, cellular analysis, drug development, and cell biology.

  • LONZA - Lonza is a global provider of biopharmaceuticals with products in the following areas: wood protection, water treatment, industrial solutions, agro-ingredients, pharmaceutical & biotechnology, and bioresearch. The market for the firm is divided into specialized ingredients and pharma & biotech. As part of a strategic attempt to improve its business, the firm signed the United Nations Global Compact in March 2009. Lonza has activities in over 100 locations and offices worldwide, including North America, Europe, Asia, and other regions. Due to the explosive rise of cell and gene therapy research worldwide in 2017, the corporation concentrated its efforts on restructuring its Emerging Technologies division. Singapore, Portsmouth (U.S.), Maastricht/Geleen (NL), and Houston (U.S.) are its four global centers of excellence for cell and gene therapy.

  • QIAGEN - Publicly traded biotech business QIAGEN has operations in more than 25 nations, including the United States, the United Kingdom, Germany, the Netherlands, France, and China. Assay technologies for molecular diagnostics, pharmaceutical, academic, and applied testing are the company's main business. NGS, molecular diagnostics, food & safety testing, bioinformatics, animal & veterinary testing, human ID & forensics, and in-life science research are among the products it offers. Global Pharmaceutical Solution, Suyog Diagnostics, Tecnolab, and UniMed Ltd. are some of QIAGEN's importers and business partners. Assay technology solutions are provided by QIAGEN in a joint venture with EVOTEC BioSystems AG and PreAnalytiX.

  • F. HOFFMANN-LA ROCHE LTD - Pharmaceutical and diagnostic product development and manufacturing are the activities of F. Hoffmann-La Roche Ltd. It is divided into two business segments: diagnostics and medicines. Drugs for infectious, cardiovascular, respiratory, oncological, metabolic, central nervous system, and autoimmune illnesses are produced by the pharmaceuticals section. Roche Diagnostics operates in a variety of market sectors, including clinical laboratory systems and patient self-monitoring. The company's main business division, Roche Professional Diagnostics, offers instruments, tests, and solutions to ensure accurate and reasonably priced results delivery. The Roche Group company Ventana Medical is engaged in the assay and kit development for in-situ hybridization methods. The molecular diagnostics firm GeneWeave Biosciences and the sequencing businesses Ariosa Diagnostics, Signature Diagnostics, CAPP Medical, and Kapa Biosystems were bought by the corporation. It operates internationally in Europe, Africa, Asia, North America, South America, and Oceania. It has about 26 production locations globally. By paying USD 12.5 million to buy Mirus Bio LLC in July 2008, F. Hoffmann-La Roche Ltd. increased its technological capabilities.

  • MIRUS BIO LLC - A privately held biotechnology business, Mirus Bio LLC is focused on the creation, advancement, and marketing of technologies and products based on nucleic acids. Labelling research reagents and nucleic acid transfection reagents are among its product offerings. With global distribution channels, the company's operations sector offers stem cell transfection, virus protection, RNAi gene slicing, large-scale protein protection, stable cell-line production, co-transfection, and electroporation. It provides low-toxicity transfection formulations, toxicity reagents, and nucleic acid labelling technologies. Roche purchased Mirus Bio LLC in July 2008 to further with RNAi delivery applications.

  • BIO-RAD LABORATORIES INC. - Bio-Rad Laboratories serves the food science, clinical diagnostics, and life sciences research industries with instruments and services. It provides solutions for cutting-edge scientific research and development initiatives and has a global network of activities. In addition, it provides a venue for the introduction of novel technologies in a variety of industries, including drug discovery, proteomics, genomics, food safety, and medical diagnostics. Bio-Rad is divided into two business segments: life science and clinical diagnostics. To support clinical laboratories in the diagnostics market, the company's clinical diagnostics business sells, produces, and maintains test kits, test systems, specific quality controls, and informatics systems. The life science sector is engaged in the creation, production, and distribution of reagents, lab equipment, and apparatus utilized in clinical research, food testing protocols, and other related fields. Reagents, apparatus, and software for the IVD test industry are all part of its product line. More than 300 clinical diagnostic assays are available for IVD application. Its clinical diagnostics branches are situated at the following locations: Cambridge, Massachusetts; Lille, Greater Paris area, France; Nazareth-Eke, Belgium; Cressier, Switzerland; Dreieich, Germany; Hercules, Benicia, & Irvine, California; and the Greater Seattle area, Washington.

  • MERCK KGAA - German multinational Merck KGaA is a supplier of products and solutions for the medical field. It is involved in three areas of business: performance materials, life science, and healthcare. It operates in Africa, Latin America, Asia Pacific, Europe, and North America. The portfolio of the Merck group includes more than 300,000 goods, such as end-to-end bioprocessing systems, antibodies & cell lines, lab water systems, and genome editing tools. Sigma Aldrich Co. LLC was acquired by Merck and commenced as a subsidiary of Merck KGaA following the announcement of the purchase in November 2015.

  • SIGMA-ALDRICH INC. - Three market-focused business segments make up Sigma Aldrich, Inc.: research, SAFC commercials, and applied business. It offers around 200,000 goods and instruments in many categories—such as analytical, chromatography, spectroscopy, acid-base titration, inorganic catalysts, chemical synthesis, organometallics, and salts and solvents—through these units. Antibiotics, biochemical reagents, enzymes, inhibitors, and substrates are examples of products in the life sciences. The business is active in more than 37 nations. Fundamental research, product and process development, manufacturing and production, and regulatory compliance are among its offerings. Custom capabilities including small- and large-molecule manufacturing, medication and process development, and genomic and proteomic solutions are also available.

  • MERCK MILLIPORE - Merck Millipore serves the pharmaceutical, biotechnology, and bioscience research sectors with instruments and services. Following its acquisition by Merck in 2010, Millipore Corporation continued to function as a Merck company dedicated to life science instruments. Under the brand name EMD Millipore, the corporation does business in North America. It is a member of the Merck Group and is referred to as Merck Millipore outside of North America. Test strips, reference materials, equipment for biopharmaceutical manufacturing, Chromolith products, and ultrafiltration solutions are among the more than 60,000 goods that the firm sells.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Transfection Reagents & Equipment Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2019, historic information from 2014 to 2018, and forecast from 2020 to 2025). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Transfection Reagents & Equipment Market Report Assumptions:

  • The report provides market value for the base year 2019 and a yearly forecast till 2025 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon